OMLIAGO
Live / Applied — Fifth extension granted (statement of use) (as of 13 Mar 2026)
What this means for you
Not registered yet, but its 08 Jun 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97449122
- Mark type
- Stylized text
- Filed
- 08 Jun 2022
- Published for opposition
- 28 Feb 2023
- Attorney of record
- Jelena Libby
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical oncology preparations
Owner
- Genentech, Inc., South San Francisco, CA, US
- Genentech, Inc., South San Francisco, CA, US
Prosecution history
- 13 Mar 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 13 Mar 2026 — SOU EXTENSION 5 GRANTED
- 08 Oct 2025 — SOU EXTENSION 5 FILED
- 12 Mar 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 09 Oct 2025 — SOU TEAS EXTENSION RECEIVED
- 17 Apr 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 17 Apr 2025 — SOU EXTENSION 4 GRANTED
- 17 Apr 2025 — SOU EXTENSION 4 FILED
- 16 Apr 2025 — SOU TEAS EXTENSION RECEIVED
- 14 Oct 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 14 Oct 2024 — SOU EXTENSION 3 GRANTED
- 14 Oct 2024 — SOU EXTENSION 3 FILED
- 14 Oct 2024 — SOU TEAS EXTENSION RECEIVED
- 16 Apr 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 15 Apr 2024 — SOU EXTENSION 2 GRANTED